Results 81 to 90 of about 43,287 (326)

Uses of Botulinum Toxin in Headache and Facial Pain Disorders: An Update

Toxins
Botulinum toxin is a neurotoxin that is used in the treatments for several medical conditions, such as dystonia, spasticity, hemifacial spasm, overactive bladder, and hyperhidrosis.
Pedro Augusto Sampaio Rocha-Filho, Moises Dominguez, Christopher L. Robinson, Sait Ashina   +3 more
doaj   +1 more source

Anticholinergic Burden and Botulinum Toxin Needs after Deep Brain Stimulation in Adult and Pediatric Patients with Dystonia

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Anticholinergic medications and botulinum neurotoxin injections are established treatments for dystonia, yet they carry potential side effects and practical challenges. Deep brain stimulation (DBS) is offered in case of poor response to these approaches.
Marcela A. Montiel, Alessandro Magliozzi, Wei Kang Lim, Carolina Gorodetsky, George M. Ibrahim, Alfonso Fasano   +5 more
wiley   +1 more source

Recombinant rabies virus particles presenting botulinum neurotoxin antigens elicit a protective humoral response in vivo

Molecular Therapy: Methods & Clinical Development, 2014
Botulinum neurotoxins are one of the most potent toxins found in nature, with broad medical applications from cosmetics to the treatment of various neuropathies.
Andrew W Hudacek, Fetweh H Al-Saleem, Mallory Willet, Travis Eisemann, Jeffrey A Mattis, Lance L Simpson, Matthias J Schnell   +6 more
doaj   +1 more source

Segmental and Multifocal Isolated Dystonias: Similarities and Differences

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Whether the traditional distinction between segmental and multifocal dystonia is clinically or scientifically useful remains unclear. Objective To evaluate whether idiopathic isolated adult‐onset segmental and multifocal dystonia can be differentiated based on clinical features other than the contiguity of affected body regions ...
Hyder A. Jinnah, Vittorio Velucci, Daniele Belvisi, Gamze Kilic‐Berkmen, Joel S. Perlmutter, Laura J. Wright, Christine Klein, Jeanne S. Feuerstein, Steven Bellows, Joseph Jankovic, Cynthia Comella, Richard L. Barbano, Aparna Wagle Shukla, Stephen G. Reich, Mark S. LeDoux, Alberto J. Espay, Kevin R. Duque, Florence C.F. Chang, Victor S.C. Fung, Sarah Pirio‐Richardson, Carmen Terranova, Emile S. Moukheiber, Sarah Idrissi, Barbara Vitucci, Susan H. Fox, Samuel Frank, Natividad Stover, Brian D. Berman, Rachel Saunders‐Pullman, William G. Ondo, Christopher L. Groth, Marcello Esposito, Laura Avanzino, Francesco Bono, Roberto Erro, Marcello Mario Mascia, Antonella Muroni, Alfredo Berardelli, Giovanni Defazio   +38 more
wiley   +1 more source

Safety and Pharmacokinetics of a Four Monoclonal Antibody Combination Against Botulinum C and D Neurotoxins. [PDF]

, 2019
Botulism is caused by botulinum neurotoxin (BoNT), the most poisonous substance known. BoNTs are also classified as Tier 1 biothreat agents due to their high potency and lethality.
Cobb, Ronald R, Conrad, Fraser, Espinoza, Yero, Garcia-Rodriguez, Consuelo, Kimbler, Angie, Kraus, Carl N, Marks, James D, Martinez, Zachary, Pham, Khanh, Riling, Kathryn, Snow, Doris M, Tomic, Milan T, Wong, David   +12 more
core  

Guideline on the use of onabotulinumtoxinA in chronic migraine. a consensus statement from the European Headache Federation [PDF]

, 2018
OnabotulinumtoxinA is being increasingly used in the management of chronic migraine (CM). Treatment with onabotulinumtoxinA poses challenges compared with traditional therapy with orally administered preventatives.
Ahmed, Fayyaz, Ashina, Messoud, Bendtsen, Lars, Hospital Universitari Vall d'Hebron, Martelletti, Paolo, Mitsikostas, Dimos, Pozo-Rosich, Patricia, Sacco, Simona, Universitat Autònoma de Barcelona   +8 more
core   +3 more sources

Botulism: life-threatening illness

One Health & Risk Management, 2021
Introduction. Botulism is a potentially fatal syndrome of diffuse, flaccid paralysis caused by botulinum neurotoxin (BoNT), produced by the bacterium Clostridium botulinum.
Adan Raed ABO ARKIA
doaj  

Clostridium botulinum C3 Toxin for Selective Delivery of Cargo into Dendritic Cells and Macrophages [PDF]

, 2022
Maximilian Fellermann, Mia Stemmer, Reiner Noschka, Fanny Wondany, Stephan Fischer, Jens Michaelis, Steffen Stenger, Holger Barth   +7 more
openalex   +1 more source

The Impact of Social Determinants of Health on Facial Synkinesis Severity

The Laryngoscope, EarlyView.
Alexander J. Barna, Amy Wang, Nicole G. DeSisto, Rahul K. Sharma, Scott J. Stephan, Priyesh N. Patel, Shiayin F. Yang   +6 more
wiley   +1 more source

Investigating Sleep Concerns in Cervical Dystonia

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Heterogenous, small cohorts, and co‐occurrence of pain and psychiatric burden complicate understanding of sleep in dystonia. Objective To investigate sleep concerns in cervical dystonia (CD). Methods Longitudinal data from CD‐PROBE on subjects who were toxin‐naïve, new to practice, or without injections for at least 16 weeks were ...
Abhimanyu Mahajan, David Andrés González, Cynthia Comella   +2 more
wiley   +1 more source